Preparing the way for novel blood-based biomarkers and disease-modifying treatments for Alzheimer's disease in the NHS in the UK

J R Soc Med. 2025 Mar;118(3):78-81. doi: 10.1177/01410768241311139. Epub 2025 Jan 28.

Authors

Roxanna Korologou-Linden^{1

2}, Lefkos Middleton^{1

3}, Azeem Majeed^{2

3}, Dasha Nicholls^{2

3}, Oliver Robinson^{1

4}, Benedict Hayhoe^{2

3}

Affiliations

¹ Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London W6 8RP, UK.
² NIHR Applied Research Collaboration Northwest London, London W12 0BZ, UK.
³ Department of Primary Care and Public Health, Imperial College London, London W12 0BZ, UK.
⁴ MRC Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W12 0BZ, UK.

PMID: 39873535
PMCID: PMC11775932 (available on 2028-01-28)
DOI: 10.1177/01410768241311139

No abstract available

Publication types

Research Support, Non-U.S. Gov't